Related Experiment Videos
[Changes in immunologic indices in patients with brain tumors]
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko
|November 1, 1985
Summary
Brain tumor patients show immune system changes, including lower antibody levels and altered T and B lymphocyte counts. Neurosensitization and autoimmune responses were also observed, correlating with tumor severity and treatment outcomes.
Area of Science:
- Immunology
- Neuro-oncology
- Autoimmunity
Context:
- Patients diagnosed with brain tumors often exhibit complex immunological alterations.
- Understanding these immune dysregulations is crucial for managing brain tumor progression and treatment response.
Purpose:
- To investigate the immunological profile of patients with brain tumors.
- To identify specific immune markers, including antibody levels and lymphocyte populations.
- To assess the development of neurosensitization and autoimmune responses in these patients.
Summary:
- Complex immunological examinations in brain tumor patients revealed diminished IgM and IgG antibody levels.
- A reduction in T lymphocytes was observed, accompanied by a compensatory increase in B lymphocytes.
- Allergic tests indicated the development of neurosensitization, evidenced by leukocyte injury, agglomeration, and migration inhibition.
- Immune disorders and autoimmune shifts were found to correlate with the stage of organism compensation, tumor malignancy, and surgical outcomes.
Impact:
- This study highlights significant immune system dysfunctions in brain tumor patients.
- Findings suggest potential biomarkers for disease staging, malignancy assessment, and predicting treatment efficacy.
- The observed neurosensitization and autoimmune shifts warrant further investigation for therapeutic targeting.